DeutschNewstral
Article
The Times of India on 2021-12-05 22:53
To test vaccine efficacy, ICMR isolating Omicron strain
Related news
- ICMR-NIV isolates Omicron Covid strainThe Times of India
- India's 1st strain-specific vaccine targeting Omicron is in sightThe Times of India
- Omicron spreads faster and weakens vaccine efficacy: WHOThe Times of India
ICMR approves India-made kit to detect OmicronThe Hindu- COVID-19 | Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR studyThe Hindu
- ICMR invites bids to develop vaccine for monkeypox virusThe Hindu
- Omicron BQ.1 strain, dominant in US, now found in IndiaThe Times of India
- Covid vaccine: ICMR teams up with BBILThe Times of India
- Coronavirus | ICMR, Bharat Biotech tie up for Indian COVID-19 vaccineThe Hindu
- 'Evaluate efficacy of vaccines against Omicron'The Times of India
- Bid to fast-track vaccine development: ICMRThe Times of India
- Wuhan-like coronavirus strain isolated in India: ICMRThe Hindu
- Half of studied Omicron cases in India fully vaccinated: ICMRThe Hindu
- Coronavirus | Very few post-vaccine infections, says ICMRThe Hindu
‘Double Mutant’ Covid Variant: Here’s What We Know As Israel Reports Vaccine Efficacy Against Variant First Detected In IndiaForbes- Covid live: Delta still dominant strain circulating in India, says ICMRThe Times of India
- New Omicron strain more immune evasive: ExpertsThe Times of India
- Covid-19: Delta variant still dominant circulating strain in India, says ICMRThe Times of India
- Omicron: ICMR recommends two-dose vaccination, is fine with current Covishield gapThe Times of India
Vaccine efficacy for Omicron has likely dropped: Moderna CEONew York Post